Literature DB >> 30995644

NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis - Correlations with Disease Severity.

Alexandru Radu Mihailovici, Ionuț Donoiu, Dan Ionuț Gheonea, Oana Mirea, Georgică Costinel Târtea, Maria Buşe, Veronica Calborean, Cosmin Obleagă, Vlad Pădureanu, Octavian Istrătoaie.   

Abstract

determined. Liver disease severity in patients with cirrhosis was established by Child-Pugh class, MELD score and presence/absence of ascites.
Results: Plasma levels of NT-proBNP were significantly higher in cirrhotic patients than in the healthy subjects. NT-proBNP levels were also significantly elevated in Child-Pugh class C patients compared to those in class B and A. Left atrium size, diastolic function, left ventricular wall thickness and left ventricular ejection fraction were significantly altered in cirrhotic patients compared to controls. Advanced cirrhosis and high levels of NT-proBNP were significantly associated with increased left atrium volume and signs of cardiac diastolic dysfunction. We also observed significant differences between quartile groups of MELD score for the following: NT-proBNP, Troponin I, left atrium volume, left ventricle wall thickness, lateral wall and septum systolic tissue doppler velocities and global longitudinal strain.
Conclusion: NT-proBNP is increased in patients with cirrhosis and is correlated with the severity of liver disease as established by Child-Pugh class, MELD score and presence of ascites. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Year:  2019        PMID: 30995644      PMCID: PMC6771067          DOI: 10.1159/000499930

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  29 in total

1.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

2.  Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?

Authors:  F Wong; S Siu; P Liu; L M Blendis
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

3.  B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.

Authors:  Joana Pimenta; Cristiana Paulo; André Gomes; Sérgio Silva; Francisco Rocha-Gonçalves; Paulo Bettencourt
Journal:  Liver Int       Date:  2010-05-14       Impact factor: 5.828

4.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 5.  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

Authors:  Peter A McCullough; Torbjørn Omland; Alan S Maisel
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

6.  Left ventricular diastolic function in liver cirrhosis.

Authors:  G Finucci; A Desideri; D Sacerdoti; M Bolognesi; C Merkel; P Angeli; A Gatta
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

7.  The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.

Authors:  Rania Nancy Rabie; Massimo Cazzaniga; Francesco Salerno; Florence Wong
Journal:  Am J Gastroenterol       Date:  2009-06-16       Impact factor: 10.864

8.  LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.

Authors:  André Nazar; Mónica Guevara; Marta Sitges; Carlos Terra; Elsa Solà; Carina Guigou; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

Review 9.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

10.  NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.

Authors:  Franz Hartmann; Milton Packer; Andrew J S Coats; Michael B Fowler; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Alain Castaigne; Jürgen Trawinski; Ildiko Amann-Zalan; Silke Hoersch; Hugo A Katus
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more
  2 in total

1.  Evaluation of subclinical ventricular systolic dysfunction assessed using global longitudinal strain in liver cirrhosis: A systematic review, meta-analysis, and meta-regression.

Authors:  Denio A Ridjab; Ignatius Ivan; Fanny Budiman; Riki Tenggara
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

2.  Association of N- terminal Pro Brain Natriuretic Peptide with Echocardiographic Measures of Diastolic Dysfunction in Cirrhosis.

Authors:  Ajmera Jail Singh; Mukta Wyawahare; Krishna Sarin; Soundravally Rajendiran; Dharanipragada K S Subrahmanyam; Santhosh Satheesh
Journal:  Adv Biomed Res       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.